Piper Sandler Upgrades Macerich (LSE:0JX5)

Piper Sandler upgraded Macerich (LSE:0JX5) to Neutral on May 23, 2025, with an average one-year price target of 20.44 GBX, representing a potential 36.06% upside from the latest closing price; however, projected annual revenue is expected to decrease by 13.90% to 872MM. Institutional ownership has increased by 2.92% in the last three months, with 664 funds holding positions, although some major shareholders like Smead Capital Management and SMVLX have reduced their holdings, while others such as IJR, VGSIX and VTSMX increased their positions.

Analysis

Piper Sandler's upgrade of Macerich (LSE:0JX5) to Neutral from Underweight on May 23, 2025, accompanied by an average one-year price target of 20.44 GBX, suggests a substantial 36.06% potential upside from its latest closing price of 15.02 GBX. This analyst revision occurs despite a challenging financial forecast for Macerich, which includes a projected annual revenue decrease of 13.90% to 872MM and a nominal projected non-GAAP EPS of 0.01. Institutional sentiment, as indicated by Fintel data, shows a net increase in engagement: the number of funds reporting positions rose by 3.11% in the last quarter to 664, total institutional share ownership increased by 2.92% to 324,831K shares, and the average portfolio weight dedicated to 0JX5 grew by 13.72%. However, a closer look at major shareholders reveals a divergence: Smead Capital Management reduced its holding by 9.53% (to 18,214K shares) and its Smead Value Fund (SMVLX) decreased its position by 5.54%. In contrast, passive investment vehicles like iShares Core S&P Small-Cap ETF (IJR), Vanguard Real Estate Index Fund Investor Shares (VGSIX), and Vanguard Total Stock Market Index Fund Investor Shares (VTSMX) increased their holdings by 13.35%, 11.42%, and 11.45% respectively, indicating varied reactions across different investor types to the company's prospects.

Key Decisions for Investors

• Investors should carefully weigh Piper Sandler's 'Neutral' rating and the 36.06% price target upside for Macerich (LSE:0JX5) against the company's projected 13.90% annual revenue decline and minimal non-GAAP EPS.
• Monitor Macerich's upcoming financial reports to ascertain if revenue trends align with or deviate from the projected 872MM, and track shifts in institutional ownership, paying attention to the contrasting actions of active managers versus passive funds.
• Given the mixed signals of an analyst upgrade alongside deteriorating revenue forecasts and diverging institutional activity, a cautious approach is warranted; existing investors might hold while awaiting further fundamental clarity, whereas new investors should thoroughly assess the risk-reward profile tied to the significant revenue headwinds before considering an investment.